236 related articles for article (PubMed ID: 19925365)
1. Non-steroid anti-inflammatory drugs in the treatment of patent ductus arteriosus in European newborns.
Guimarães H; Rocha G; Tomé T; Anatolitou F; Sarafidis K; Fanos V
J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():77-80. PubMed ID: 19925365
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic closure of the ductus arteriosus: benefits and limitations.
Mercanti I; Boubred F; Simeoni U
J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():14-20. PubMed ID: 19925358
[TBL] [Abstract][Full Text] [Related]
3. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
Supapannachart S; Limrungsikul A; Khowsathit P
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
[TBL] [Abstract][Full Text] [Related]
4. A second course of ibuprofen is effective in the closure of a clinically significant PDA in ELBW infants.
Richards J; Johnson A; Fox G; Campbell M
Pediatrics; 2009 Aug; 124(2):e287-93. PubMed ID: 19651568
[TBL] [Abstract][Full Text] [Related]
5. Nonsteroidal anti-inflammatory drugs (NSAIDs) in the newborn - which ones?
Aranda JV; Beharry KD; Valencia GB
J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():21-2. PubMed ID: 19925359
[TBL] [Abstract][Full Text] [Related]
6. Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants.
Cherif A; Jabnoun S; Khrouf N
Am J Perinatol; 2007 Jun; 24(6):339-45. PubMed ID: 17564958
[TBL] [Abstract][Full Text] [Related]
7. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.
Chotigeat U; Jirapapa K; Layangkool T
J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S563-9. PubMed ID: 14700149
[TBL] [Abstract][Full Text] [Related]
8. Neonatal necrotizing enterocolitis with intestinal perforation in extremely premature infants receiving early indomethacin treatment for patent ductus arteriosus.
Fujii AM; Brown E; Mirochnick M; O'Brien S; Kaufman G
J Perinatol; 2002; 22(7):535-40. PubMed ID: 12368968
[TBL] [Abstract][Full Text] [Related]
9. Ibuprofen: alternative treatment for patent ductus arteriosus.
Flores M
Neonatal Netw; 2003; 22(2):27-31. PubMed ID: 12696723
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological closure of patent ductus arteriosus: effects on pulse pressure and on endothelin-1 and vasopressin excretion.
Zanardo V; Vedovato S; Chiozza L; Faggian D; Favaro F; Trevisanuto D
Am J Perinatol; 2008 Jun; 25(6):353-8. PubMed ID: 18509786
[TBL] [Abstract][Full Text] [Related]
11. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants.
Jaillard S; Larrue B; Rakza T; Magnenant E; Warembourg H; Storme L
Ann Thorac Surg; 2006 Jan; 81(1):231-4. PubMed ID: 16368371
[TBL] [Abstract][Full Text] [Related]
12. Comparison of oral ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants.
Fakhraee SH; Badiee Z; Mojtahedzadeh S; Kazemian M; Kelishadi R
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Oct; 9(5):399-403. PubMed ID: 17937843
[TBL] [Abstract][Full Text] [Related]
13. Is there an optimal timing for surgical ligation of patent ductus arteriosus in preterm infants?
Vida VL; Lago P; Salvatori S; Boccuzzo G; Padalino MA; Milanesi O; Speggiorin S; Stellin G
Ann Thorac Surg; 2009 May; 87(5):1509-15; discussion 1515-6. PubMed ID: 19379895
[TBL] [Abstract][Full Text] [Related]
14. Variation and comparative effectiveness of patent ductus arteriosus pharmacotherapy in extremely low birth weight infants.
ElHassan NO; Bird TM; King AJ; Ambadwar PB; Jaquiss RD; Kaiser JR; Robbins JM
J Neonatal Perinatal Med; 2014 Jan; 7(3):229-35. PubMed ID: 25322995
[TBL] [Abstract][Full Text] [Related]
15. Ibuprofen lysine for the prevention and treatment of patent ductus arteriosus.
Pai VB; Sakadjian A; Puthoff TD
Pharmacotherapy; 2008 Sep; 28(9):1162-82. PubMed ID: 18752387
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and renal tolerability of ibuprofen vs. indomethacin in preterm infants with patent ductus arteriosus.
Fanos V; Benini D; Verlato G; Errico G; Cuzzolin L
Fundam Clin Pharmacol; 2005 Apr; 19(2):187-93. PubMed ID: 15810899
[TBL] [Abstract][Full Text] [Related]
17. Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method.
Desfrere L; Zohar S; Morville P; Brunhes A; Chevret S; Pons G; Moriette G; Rey E; Treluyer JM
J Clin Pharm Ther; 2005 Apr; 30(2):121-32. PubMed ID: 15811164
[TBL] [Abstract][Full Text] [Related]
18. Nonsteroidal anti-inflammatory administration and patent ductus arteriosus ligation, a survey of practice preferences at US children's hospitals.
Slaughter JL; Reagan PB; Bapat RV; Newman TB; Klebanoff MA
Eur J Pediatr; 2016 Jun; 175(6):775-83. PubMed ID: 26879388
[TBL] [Abstract][Full Text] [Related]
19. The management of patent ductus arteriosus in Australia and New Zealand.
Hoellering AB; Cooke L
J Paediatr Child Health; 2009 Apr; 45(4):204-9. PubMed ID: 19291140
[TBL] [Abstract][Full Text] [Related]
20. Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants.
Erdeve O; Yurttutan S; Altug N; Ozdemir R; Gokmen T; Dilmen U; Oguz SS; Uras N
Arch Dis Child Fetal Neonatal Ed; 2012 Jul; 97(4):F279-83. PubMed ID: 22147286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
